D-607-2013 Class III Terminated

Recalled by Pfizer Inc — Peapack, NJ

FDA drug recall D-607-2013 was initiated by Pfizer Inc on May 31, 2013 and is designated Class III. Reason for recall: Failed Dissolution Specification The recall status is terminated (terminated Jun 5, 2015). Affected quantity: 5,410 botlles.

Recall details

Product Type
Drugs
Report Date
Jun 26, 2013
Initiation Date
May 31, 2013
Termination Date
Jun 5, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,410 botlles

Product description

Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.

Reason for recall

Failed Dissolution Specification

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: a) C120138, Exp 07/13; b) C120137, Exp 07/13

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-607-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-607-2013. Report a data issue: hello@regdatalab.com.